Methotrexate significantly lowers systolic blood pressure in newly diagnosed RA patients compared to sulfasalazine, potentially reducing cardiovascular risk. The study provides prospective comparative ...

Methotrexate is the gold standard of care for RA, but it can also disrupt a pregnancy. In states with strict anti-abortion laws, some women with RA cannot get their routine medication easily or ...

Feb. 27, 2004 — The combination of etanercept and methotrexate reduces the symptoms and joint destruction of rheumatoid arthritis more than either drug alone, according to the results of a randomized, ...

The average age of the RA patients was 62 (20 92 years), and the average age of the PsA patients was 49 (9 76 years). Females outnumbered males in the RA group by approximately 3:1, while males ...

Please provide your email address to receive an email when new articles are posted on . Patients with RA treated with first-line upadacitinib over 5 years had greater reductions in disease activity vs ...

Tofacitinib beats methotrexate for rheumatoid arthritis Increased side effects, including development of herpes zoster, were seen in patients treated with tofacitinib. Methotrexate is the most ...

Please provide your email address to receive an email when new articles are posted on . Upadacitinib monotherapy, at 15 or 30 mg daily, significantly improves clinical, radiographic and ...

While a 1-year course of methotrexate improved physical function, pain, morning joint stiffness, and joint inflammation, it did not prevent the development of clinical arthritis. Among patients with ...

Leflunomide and methotrexate are prescription drugs used to treat rheumatoid arthritis (RA). Methotrexate is also used to treat certain other conditions, including psoriasis. This article explains the ...

UPPER NYACK, N.Y.--(BUSINESS WIRE)--CreakyJoints®, a Global Healthy Living Foundation patient community, will present five posters, some in partnership with major academic institutions, at the 2019 ...

"Alvotech and Advanz announce EC approval for Gobivaz biosimilar" was originally created and published by Pharmaceutical ...